US FDA approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin, for use among adult patients of diabetes mellitus on 27th June, 2014
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm403122.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm403122.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery.
No comments:
Post a Comment